| |
| | WAM: Children Show Improved Compliance With Oral Leukotriene Receptor Antagonist (Site not responding. Last check: 2007-10-12) |
 | | Data supporting this conclusion were presented at the World Asthma Meeting by Alan Luskin, MD, of the University of Wisconsin in Madison, Wisconsin, and his colleagues at the Institute for Effectiveness Research in Bridgewater, New Jersey, and at Merck and Co in Whitehouse Station, New Jersey, in the United States. |
 | | A total of 11,790 patients were enrolled; 84 percent were treated with inhaled corticosteroids, 11 percent with leukotriene receptor antagonists (LTRAs); 5 percent were treated with with long-acting beta-agonists (LBAs). |
 | | After nine months, 42.3 percent of children treated with LTRAs were still using the medication; 19.9 percent of those treated with inhaled corticosteroids and 16.6 percent of those treated with LBAs were still using the medication. |
| www.pslgroup.com /dg/201016.htm (411 words) |
|